Noxopharm Limited Stock Market Value
| NOXOF Stock | USD 0.03 0.00 0.00% |
| Symbol | Noxopharm |
Noxopharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Noxopharm's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Noxopharm.
| 02/16/2024 |
| 04/16/2024 |
If you would invest 0.00 in Noxopharm on February 16, 2024 and sell it all today you would earn a total of 0.00 from holding Noxopharm Limited or generate 0.0% return on investment in Noxopharm over 60 days. Noxopharm is related to or competes with SCOR PK, Putnam Short, Royce Opportunity, C4 TherapeuticsInc, LSI Industries, Essential Utilities, and RenaissanceRe Holdings. Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancer... More
Noxopharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Noxopharm's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Noxopharm Limited upside and downside potential and time the market with a certain degree of confidence.
Noxopharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Noxopharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Noxopharm's standard deviation. In reality, there are many statistical measures that can use Noxopharm historical prices to predict the future Noxopharm's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Noxopharm's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Noxopharm Limited Backtested Returns
We have found three technical indicators for Noxopharm, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Noxopharm are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Noxopharm Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Noxopharm time series from 16th of February 2024 to 17th of March 2024 and 17th of March 2024 to 16th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Noxopharm Limited price movement. The serial correlation of 0.0 indicates that just 0.0% of current Noxopharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Noxopharm Limited lagged returns against current returns
Autocorrelation, which is Noxopharm pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Noxopharm's pink sheet expected returns. We can calculate the autocorrelation of Noxopharm returns to help us make a trade decision. For example, suppose you find that Noxopharm has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Noxopharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Noxopharm pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Noxopharm pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Noxopharm pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Noxopharm Lagged Returns
When evaluating Noxopharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Noxopharm pink sheet have on its future price. Noxopharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Noxopharm autocorrelation shows the relationship between Noxopharm pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Noxopharm Limited.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Noxopharm Correlation, Noxopharm Volatility and Noxopharm Alpha and Beta module to complement your research on Noxopharm. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Noxopharm Pink Sheet analysis
When running Noxopharm's price analysis, check to measure Noxopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Noxopharm is operating at the current time. Most of Noxopharm's value examination focuses on studying past and present price action to predict the probability of Noxopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Noxopharm's price. Additionally, you may evaluate how the addition of Noxopharm to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Noxopharm technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.